NASDAQ · Shell Companies · USD

Aimei Health Technology Co., Ltd (AFJK) Stock Analysis

Aimei Health Technology Co., Ltd (AFJK) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

AFJK

$12.20

$0.00 (0.00%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AFJK with… →

AFJK Key Statistics

As of Sep 4, 2026

Trading

Open: $12.59
Previous Close: $12.20
Day's Range: 12.15–12.62
52-Week Range: 6.75–130.37
Volume: 114.40K
Beta: 0.85

Valuation

Market Cap: $38.63M
P/E Ratio: 174.29
EPS (ttm): 0.07

Financials (FY)

Revenue (FY): $0.00
Net Income (FY): $1.06M−58.48%
Profit margin: 0.00%
Shares Outstanding: 3.17M
1-Year Return: +8.44%

Dividend and dates

Avg Volume: 25.02K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

AFJK Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

+5.42%+498.22%−80.94%

202420252026*

Year	Return
2026 (partial year)	−80.94%
2025	+498.22%
2024	+5.42%

As of September 4, 2026.

AFJK Revenue and Earnings by Fiscal Year

FY ends December

Fiscal year	Revenue	Net income	Net margin
2025	$0.00	$1.06M	—
2024	$0.00	$2.55M	—

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$0.00	—	−$835.76K	$1.06M	—
2024	$0.00	—	−$1.06M	$2.55M	—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

AFJK Valuation vs Shell Companies Median

Median of 587 stocks

Metric	AFJK	Shell Companies median	vs median
P/E	174.29	45.20	3.9x the median
Profit margin	0.00%	0.00%	0.0 pts above

Medians across 587 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Aimei Health Technology Co., Ltd (AFJK) is capitalised at $38.63M on the latest close. It is classified in the Shell Companies industry, within the Financial Services sector.

AFJK last closed at $12.20 on September 4, 2026. The close was unchanged from the previous session. The 52-week range on file runs from $6.75 to $130.37. The latest close sits 80.74% above that 52-week low.

Financial Health

In fiscal 2025, Aimei Health Technology Co., Ltd reported revenue of $0.00. Net income for the same year was $1.06M. That is −58.48% against the prior fiscal year. The reported profit margin is 0%. Earnings per share on a trailing basis come to 0.07.

Valuation Assessment

On trailing earnings, the shares are priced at 174.29 times earnings. That is 3.9 times the Shell Companies median of 45.2. The medians here are taken across 587 Shell Companies companies that report the metric.

Beta against the wider market is reported at 0.85. Daily returns over the trailing 2 years annualize to a volatility of 735.37%. Over the trailing twelve months the price has returned +8.44%. The stored price history starts on January 22, 2024, and the total return since then is +20.20%.

Growth & Income

The record shows no dividend for AFJK.

2026 is still running; the price is −80.94% year to date. The strongest complete calendar year on file is 2025 at +498.22%; the weakest is 2024 at +5.42%.

Peer Comparison

Aimei Health Technology Co., Ltd (AFJK) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Aimei Health Technology Co., Ltd	AFJK	$38.63M	174.3
Churchill Capital Corp XI	CCXI	$746.38M	—
Churchill Capital Corp X	CCCX	$711.00M	—
Drugs Made In America Acquisition II Corp.	DMII	$647.83M	35.1

The Shell Companies industry average P/E ratio is 45.2x. Aimei Health Technology Co., Ltd trades at a P/E of 174.3.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

CCCX

Churchill Capital Corp X

$711.00M

DMII

Drugs Made In America Acquisition II Corp.

$647.83M

BCSS

Bain Capital GSS Investment Corp.

$602.40M

EVAC

EQV Ventures Acquisition Corp. II

$602.01M

CXII

Churchill Capital Corp XII

$594.94M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About Aimei Health Technology Co., Ltd

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.